decreased hematocrit_3110043O21Rik<tm1Lagi>/3110043O21Rik<tm1Lagi>

http://metadb.riken.jp/0000208IC57BL6C57BL6N3110043O21Riktm1Lagi3110043O21Riktm1Lagi3110043O21Riktm1Lagi

decreased hematocrit_3110043O21Rik<tm1Lagi>/3110043O21Rik<tm1Lagi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• RIKEN cDNA 3110043O21 gene
  http://metadb.riken.jp/db/mgi_rdf/MGI:1920455

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• 3110043O21Rik<tm1Lagi>/3110043O21Rik<tm1Lagi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• 3110043O21Rik<tm1Lagi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * C57BL/6N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased hematocrit
  http://purl.obolibrary.org/obo/MP_0000208

文献

http://purl.org/net/cito/citesAsAuthority

• Jie. Jiang, et.al., Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs., Neuron, 2016, 90
  http://rdf.ncbi.nlm.nih.gov/pubmed/27112497